title: Urticaria and angioedema in a patient with Behçet's disease treated with adalimumab.
authors.forename: D
authors.initials: D
authors.lastname: Sànchez-Cano
authors.forename: J L
authors.initials: JL
authors.lastname: Callejas-Rubio
authors.forename: N
authors.initials: N
authors.lastname: Ortego-Centeno
authors.forename: R
authors.initials: R
authors.lastname: Ruiz-Villaverde
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000799:Angioedema / Q000139:chemically induced*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001528:Behcet Syndrome / Q000188:drug therapy; D005260:Female; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014581:Urticaria / Q000139:chemically induced*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab